The table below shows NEOGENOMICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$727.33M
$660.57M
$591.64M
$509.73M
$484.33M
$444.45M
Cost of revenue
$413.04M
$370.47M
$347.04M
$321.83M
$297.27M
$258.56M
Gross profit
$314.29M
$290.10M
$244.60M
$187.90M
$187.06M
$185.89M
R&D
$37.08M
$31.16M
$27.31M
$30.33M
$21.87M
$8.23M
NEO annual revenue (10-K history)
NEOGENOMICS INC reported annual revenue of $727.33M for fiscal year 2025. That is up 10.1% from $660.57M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $231.81M (FY 2016) to $727.33M. Figures come from the company's audited annual reports as filed with the SEC.
